INFLATE Study: Investigation of the Safety and Performance of a Novel PTV Balloon in Patients Undergoing TAVI for Severe Aortic Stenosis
A legfontosabb adatok
- Ki végzi
- Biosensors Europe SA
- Hol
- Spanyolország9 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 93 fő, tervezett
- Kezdés
- 2025. dec. 15.
- Tervezett befejezés
- 2026. aug.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- PTV (Percutaneous Transcatheter Valvuloplasty) Balloon
- A regiszteradat frissítve
- 2026. április 16.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with severe, symptom-causing narrowing of the aortic heart valve due to calcium, who are planned for TAVI through the groin artery. A new balloon device (PTV Balloon) will be used to widen the valve during the procedure.
- Életkor
- 18 years and older
- Nem
- All sexes can join
- A betegség stádiuma
- Symptomatic severe calcific aortic stenosis of the own (native) valve. Valve area ≤1.0 cm2 (or AVA index ≤0.6 cm2/m2) AND mean pressure gradient ≥ 40mmHg OR maximal velocity ≥4.0m/s OR Doppler velocity index ≤0.25 on heart ultrasound. The local Heart Team must agree that TAVI is the right procedure and that the person can have it. A trans-femoral (through the groin) procedure must be planned.
- Korábbi kezelés
- People with a permanent pacemaker cannot join.
A részvétel fő kizáró okai
- Aortic annulus or bioprosthesis inner diameter <16 mm or >30 mm
- Existing heart rhythm conduction problems (LBBB, RBBB, AV block 2 and 3) or a permanent pacemaker
- Stroke or TIA within 6 months, heart attack within 30 days, or active infection such as endocarditis
- Ejection fraction <20%, severe tricuspid or mitral leak, or kidney failure needing continuous renal replacement therapy
- Pregnancy or plans to become pregnant, or taking part in another investigational study
A regiszter feltételei, szó szerint
Mind a 29 feltétel megnézéseKevesebb
Ki vehet részt
- Symptomatic severe calcific stenosis of a native aortic valve with an AVA ≤1.0 cm2 (or AVA index ≤0.6 cm2/m2) AND mean aortic pressure gradient ≥ 40mmHg OR maximal transaortic velocity ≥4.0m/s OR Doppler velocity index ≤0.25 on site-reported echocardiography
- Local multi-disciplinary Heart Team agrees on indication and eligibility for TAVI
- Age ≥18 years
- Patient has signed the Patient Informed Consent Form
- Patient is willing and able to comply with requirements of the study
- Patients planned for trans-femoral procedure
Ki nem vehet részt
- Acute MI ≤30 days prior to the index procedure
- Cerebrovascular accident (CVA) or transient ischemic attack (TIA) ≤6 months or prior CVA with moderate or severe disability (e.g. modified Rankin scale score >2)
- Currently participating in another investigational drug or device study
- Significant disease of the aorta that would preclude safe advancement of the TAVI system
- Severe ilio-femoral vessel disease that would preclude safe performance of the TAVI procedure
- Severe tricuspid regurgitation and/or failing right heart (site-reported)
- Evidence of active endocarditis or other acute infections
- Renal failure requiring continuous renal replacement therapy
- Untreated clinically significant coronary artery disease requiring revascularization
- Symptomatic carotid or vertebral artery disease requiring intervention or carotid/vertebral intervention within the preceding 45 days
- Severe (greater than 3+) mitral insufficiency (site-reported)
- Isolated Aortic Insufficiency
- Severe left ventricular dysfunction with ejection fraction (EF) <20% (site-reported)
- History of bleeding diathesis or coagulopathy; acute blood dyscrasias as defined: thrombocytopenia (platelets <80,000/µl), acute anemia (hemoglobin <10 g/dl), leukopenia (WBC <3000/ µl)
- Known hypersensitivity to contrast media, which cannot be adequately pre-medicated or contraindication to anticoagulant or anti-platelet medication or to nitinol alloy or to bovine tissue
- Mean aortic annulus diameter as measured by pre-procedural CT or internal diameter of the bioprosthesis is <16 mm or >30 mm
- Echocardiographic evidence of intracardiac thrombus, mass or vegetation (site-reported)
- Pregnancy or intend to become pregnant during study participation
- Unicuspid aortic valve
- Non-calcified aortic stenosis
- Identified high risk of coronary occlusion due to Sinus of Valsalva anatomy and/or bulky calcified aortic valve leaflets in close proximity to coronary ostia
- Patients with a permanent pacemaker
- Patients with pre-existing LBBB, RBBB and AV block 2 and 3
Ez a vizsgálat jelenleg itt érhető el: Spanyolország.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
This clinical investigation is being done to evaluate the safety and effectiveness of a new device, a PTV Balloon, that will be used to open up an area in the heart (the valve) before and potentially after placing a new valve in patients requiring a new heart valve.
A teljes eredeti leírásKevesebb
The main question it aims to answer is:
What percentage of patients develop new heart conduction problems after using the investigational PTV Balloon for pre-dilatation?
Participants will:
1. Undergo a TAVI procedure, where the PTV Balloon will be used for pre-dilatation and may also be used for post-dilatation. 2. Will be followed up until discharge or up to 7 days, whichever happens first.
A vizsgálat csoportja
- Biosensors PTV balloon catheterA vizsgált kezelés
Patients suffering from a severe aortic stenosis and scheduled for a TAVI.
Kezelés: PTV (Percutaneous Transcatheter Valvuloplasty) Balloon
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Investigation of the Safety and Performance of a Novel PTV Balloon in Patients Undergoing TAVI for Severe Aortic Stenosis
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. április 16.